|1.||Zeidman, R: 2 articles (11/2001 - 12/2000)|
|2.||Larsson, C: 2 articles (11/2001 - 12/2000)|
|3.||Trollér, U: 2 articles (11/2001 - 12/2000)|
|4.||Svensson, K: 2 articles (11/2001 - 12/2000)|
|5.||Kiani, Soroosh: 1 article (01/2013)|
|6.||Gokce, Noyan: 1 article (01/2013)|
|7.||Kluge, Matthew A: 1 article (01/2013)|
|8.||Fetterman, Jessica L: 1 article (01/2013)|
|9.||Rosenzweig, James: 1 article (01/2013)|
|10.||Hamburg, Naomi M: 1 article (01/2013)|
03/26/2003 - "The effect of the PKCbeta inhibitor LY379196 on the growth-suppressing effects of different chemotherapeutics on neuroblastoma cells was analyzed with MTT assays. "
11/09/2001 - "The PKCbeta-specific inhibitor LY379196 had no effect on 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced neurite outgrowth from SH-SY5Y neuroblastoma cells. "
03/26/2003 - "The effect of LY379196 on the accumulation of [3H]vincristine was also investigated The PKCbeta inhibitor LY379196 suppressed the growth of three neuroblastoma cell lines. "
12/01/2000 - "Furthermore, a PKCbeta-specific inhibitor, LY379196, suppressed the phorbol ester- and serum-supported growth of neuroblastoma cells. "
|4.||Breast Neoplasms (Breast Cancer)
08/15/2001 - "Furthermore, LY379196 inhibited bone resorption elicited by PTH in fetal rat bone organ cultures. "
08/15/2001 - "A selective antagonist of PKC-beta, LY379196, was used to determine the role of the PKC-beta isozyme in the expression of IL-6 in UMR-106 rat osteoblastic cells and in bone resorption in fetal rat limb bone organ cultures. "
|2.||Interleukin-6 (Interleukin 6)
|3.||Mifepristone (RU 486)
|7.||protein kinase C beta